Health-related quality of life, emotional burden, and neurocognitive function in the first generation of metastatic melanoma survivors treated with pembrolizumab: a longitudinal pilot study. [electronic resource]
Producer: 20200714Description: 3267-3278 p. digitalISSN:- 1433-7339
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Anxiety -- etiology
- Cancer Survivors -- psychology
- Depression -- etiology
- Female
- Humans
- Longitudinal Studies
- Male
- Melanoma -- drug therapy
- Middle Aged
- Neoplasm Metastasis
- Neurocognitive Disorders -- etiology
- Patient Reported Outcome Measures
- Pilot Projects
- Prospective Studies
- Quality of Life
- Stress, Psychological -- etiology
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.